GMP Biologics Market, By Product Type, By Application, By Service, By Manufacturing Scale, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Description

GMP Biologics Market size was valued at US$ 67,810.87 Million in 2024, expanding at a CAGR of 15.98% from 2025 to 2032.

GMP Biologics refers to biological medicines that are mass-produced in compliance with Good Manufacturing Practice (GMP) standards recognized by national and international regulatory authorities to ensure consistent quality, safety, and effectiveness. Biologics are compound therapies derived from living cells and include monoclonal antibodies, vaccines, recombinant proteins, and advanced cell and gene therapies. Due to their structural sensitivity and sophisticated production processes, strict regulatory oversight is required at every stage from raw material sourcing to final packaging.

From a global governance view, institutions such as the World Health Organization provide internationally recognized GMP guidelines adopted by more than 100 countries to harmonize pharmaceutical quality standards. In parallel, regulatory authorities, including the U.S. Food and Drug Administration and the European Medicines Agency (EMA), have reported a consistent rise in biologics and biosimilar approvals over recent years, reflecting the growing role of advanced therapies in addressing cancer, autoimmune disorders, and rare diseases. Public health data further specify that biologic products now represent a significant share of newly approved therapeutic agents in major markets, underscoring strong governmental emphasis on expanding high-quality biomanufacturing capacity and ensuring resilient pharmaceutical supply chains worldwide.

GMP Biologics Market- Market Dynamics

Rising demand for advanced biologic therapies to support long-term healthcare sustainability

Healthcare systems are increasingly prioritizing targeted biologic treatments for chronic and complex diseases due to their potential to improve outcomes and reduce long-term treatment burden. This shift toward precision medicine is accelerating the need for high-quality GMP-certified production infrastructure, contributing to steady market expansion. As chronic conditions like cancer and autoimmune disorders increasingly dominate the global disease burden, governments are prioritizing biologics to reduce long-term hospitalizations and systemic costs. For instance, the Government of India, in its Union Budget 2026-27, launched the "Biopharma SHAKTI" initiative with an outlay of $1.2 billion to establish a global manufacturing hub for biologics and biosimilars. Similarly, corporate leaders like Pfizer and Eli Lilly are scaling GMP-compliant production to meet this need, with the global biologics market projected to exceed $534 billion by 2026. By ensuring the scalable production of targeted therapies, the GMP biologics sector provides the essential infrastructure for a resilient, value-based global healthcare ecosystem.

GMP Biologics Market- Segmentation Analysis:

The Global GMP Biologics Market is segmented on the basis of Product Type, Application, Service, Manufacturing Scale, End User, and Region.

On the basis of product type global market is divided into four categories: Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, and Cell & Gene Therapies. Monoclonal Antibodies are widely acknowledged as the segment set to play the most pivotal role in the global biologics market in the near term. mAbs already account for the largest share of biologics revenue globally due to their proven effectiveness in treating major chronic and complex diseases such as cancer and autoimmune disorders, and their ability to target disease pathways with precision and fewer side effects than many traditional therapies. In fact, the U.S. Food and Drug Administration (FDA) approved a notably high number of monoclonal antibody therapies in recent years, including a record number of mAb approvals in 2024, reinforcing their clinical importance. Major biopharmaceutical players such as Roche, AbbVie, and Pfizer have built robust monoclonal antibody portfolios and continue to expand GMP-compliant production capacity to meet global demand, with blockbuster therapies like Herceptin (Roche) and Humira (AbbVie) driving sustained commercial performance and uptake.

The market is divided into three categories based on manufacturing scale: Clinical Scale, Commercial Scale, and Pilot Scale. Commercial-scale manufacturing is forecasted to register meaningful growth in the GMP biologics market at a global level because it enables the large volume, consistent production of approved biologic therapies once they clear clinical development, which is essential to meet worldwide demand for treatments such as monoclonal antibodies, vaccines, and gene-based therapies and to support broad patient access. Leading manufacturing specialists like Samsung Biologics, which has built multiple large capacity GMP plants exceeding hundreds of thousands of liters, are actively expanding their commercial production footprint to serve long term supply contracts with major pharmaceutical partners such as Pfizer and others. At the same time, regulators like the U.S. Food and Drug Administration (FDA) maintain stringent GMP expectations and approvals that underpin the transition from small-scale and clinical production to full-scale commercial biologics supply, reinforcing the central role of commercial manufacturing infrastructure in ensuring reliable, high-quality biologic availability worldwide.

GMP Biologics Market- Geographical Insights

From the geographical point of view shows that North America is expected to remains a influential hub for GMP biologics manufacturing and innovation, supported by advanced regulatory infrastructure and strong public health investment. In the United States, the U.S. Food and Drug Administration oversees stringent good manufacturing practice (GMP) compliance, ensuring high-quality biologics production, and has approved hundreds of biologic products for therapeutic use. The U.S. benefits from one of the largest concentrations of biologics manufacturing facilities and a robust pipeline of monoclonal antibodies, vaccines, and recombinant proteins, reflecting broad domestic demand and industry capability. Canada also contributes to regional strength, with biologics accounting for a significant share of national pharmaceutical expenditure, indicating sustained integration of biotherapeutic products within healthcare systems.

From an industry perception, leading pharmaceutical and biotech companies are expanding their biologics manufacturing capacity in North America to serve both domestic and export markets. U.S.-based innovators like Amgen and Pfizer operate large GMP-compliant facilities and continue to invest in next-generation biologic production technologies. These firms work closely with federal agencies to adhere to evolving quality standards while advancing production efficiency. In Canada, national regulatory guidance encourages alignment with international GMP standards, supporting cross-border pharmaceutical activities. Collectively, North America's regulatory assurance, healthcare demand, and corporate investment underpin its influential role in the global GMP biologics landscape.

China GMP Biologics Market- Country Insights

China has become an increasingly important player in biologics manufacturing, driven by proactive government policies and growing domestic industry capabilities. The National Medical Products Administration introduced a pilot program for segmented production of biological products in late 2024, enabling facilities to specialize in different stages of biologics manufacturing to improve efficiency and support compliance with GMP standards. Major Chinese firms such as WuXi Biologics and state-owned China National Pharmaceutical Group Corporation contribute significantly to the country's biologics output, including vaccines, antibody drugs, and complex therapeutic proteins. These developments reflect China's strategic focus on strengthening its manufacturing ecosystem, enhancing regulatory alignment, and supporting innovation to meet both domestic healthcare needs and expanding export opportunities.

GMP Biologics Market- Competitive Landscape:

Driven by the growing demand for advanced therapeutics and biologic treatments, the global GMP biologics market comprises both multinational pharmaceutical companies and regional manufacturers, making it a highly competitive sector. Companies distribute biologics through contract manufacturing, direct partnerships with healthcare providers, and specialized biopharmaceutical channels. Market participants compete on factors such as production quality, compliance with GMP standards, technological capabilities, cost efficiency, and regulatory alignment. Key strategies to strengthen market presence include expanding production capabilities, enhancing research and development initiatives, forming strategic partnerships, and pursuing targeted acquisitions. For example, WuXi Biologics and Samsung Biologics continue to strengthen global reach through advanced manufacturing facilities and strategic partnerships.

Recent Developments:

In December 2025, Samsung Biologics announced it would acquire its first U.S. drug production facility from GlaxoSmithKline for about $280 million, enabling expanded biologics production capacity in the United States and strengthening its long term manufacturing footprint.

In April 2025, WuXi Biologics completed its first commercial Process Performance Qualification (PPQ) campaign at a new 15,000L production line at its Hangzhou site. This milestone marks the successful scaling of one of Asia's largest single-use bioreactor systems, enhancing the company's commercial manufacturing capabilities.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GMP BIOLOGICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Samsung Biologics
WuXi Biologics
Amgen Inc.
Pfizer Inc.
Roche Holding AG
Novartis AG
Merck & Co.
Bristol Myers Squibb
Sanofi
Lonza Group
Catalent Inc.
Thermo Fisher Scientific
Cobra Biologics
AstraZeneca plc
Charles River Laboratories International, Inc.
Rentschler Biopharma SE
Others

GLOBAL GMP BIOLOGICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

Monoclonal Antibodies (mAbs)
Recombinant Proteins
Vaccines
Cell & Gene Therapies

GLOBAL GMP BIOLOGICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Oncology
Immunology
Infectious Diseases
Rare Diseases
Cardiovascular Diseases

GLOBAL GMP BIOLOGICS MARKET, BY SERVICE- MARKET ANALYSIS, 2019 - 2032

Process Development
Analytical Testing Service
Fill-Finish Service
Upstream Manufacturing
Downstream Processing

GLOBAL GMP BIOLOGICS MARKET, BY MANUFACTURING SCALE- MARKET ANALYSIS, 2019 - 2032

Clinical Scale
Commercial Scale
Pilot Scale

GLOBAL GMP BIOLOGICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

Biopharmaceutical Companies
Contract Development & Manufacturing Organizations (CDMOs)
Research Institutes
Clinical Research Organizations (CROs)

GLOBAL GMP BIOLOGICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV6158

1. GMP Biologics Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. GMP Biologics Market Snippet by Product Type
- 2.1.2. GMP Biologics Market Snippet by Application
- 2.1.3. GMP Biologics Market Snippet by Service
- 2.1.4. GMP Biologics Market Snippet by Manufacturing Scale
- 2.1.5. GMP Biologics Market Snippet by End User
- 2.1.6. GMP Biologics Market Snippet by Country
- 2.1.7. GMP Biologics Market Snippet by Region
2.2. Competitive Insights

3. GMP Biologics Key Market Trends

3.1. GMP Biologics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. GMP Biologics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. GMP Biologics Market Opportunities
3.4. GMP Biologics Market Future Trends

4. GMP Biologics Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. GMP Biologics Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. GMP Biologics Market Landscape

6.1. GMP Biologics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. GMP Biologics Market - By Product Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
- 7.1.2. Monoclonal Antibodies (mAbs)
- 7.1.3. Recombinant Proteins
- 7.1.4. Vaccines
- 7.1.5. Cell & Gene Therapies

8. GMP Biologics Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 8.1.2. Oncology
- 8.1.3. Immunology
- 8.1.4. Infectious Diseases
- 8.1.5. Rare Diseases
- 8.1.6. Cardiovascular Diseases

9. GMP Biologics Market - By Service

9.1. Overview
- 9.1.1. Segment Share Analysis, By Service, 2024 & 2032 (%)
- 9.1.2. Process Development
- 9.1.3. Analytical Testing Services
- 9.1.4. Fill-Finish Services
- 9.1.5. Upstream Manufacturing
- 9.1.6. Downstream Processing

10. GMP Biologics Market - By Manufacturing Scale

10.1. Overview
- 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 10.1.2. Clinical Scale
- 10.1.3. Commercial Scale
- 10.1.4. Pilot Scale

11. GMP Biologics Market - By End User

11.1. Overview
- 11.1.1. Biopharmaceutical Companies
- 11.1.2. Contract Development & Manufacturing Organizations (CDMOs)
- 11.1.3. Research Institutes
- 11.1.4. Clinical Research Organizations (CROs)

12. GMP Biologics Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. GMP Biologics Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. GMP Biologics Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.10. UK
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.10.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.10.5. UK Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.3.10.6. UK Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.11. France
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.11.5. France Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.3.11.6. France Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.12. Italy
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.12.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.12.5. Italy Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.3.12.6. Italy Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.13. Spain
  - 12.3.13.1. Overview
  - 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.13.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.13.5. Spain Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.3.13.6. Spain Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.14. The Netherlands
  - 12.3.14.1. Overview
  - 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.14.5. The Netherlands Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.3.14.6. The Netherlands Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Overview
  - 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.16. Russia
  - 12.3.16.1. Overview
  - 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.16.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.16.5. Russia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.3.16.6. Russia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.17. Poland
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.17.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.17.5. Poland Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.3.17.6. Poland Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.18. Rest of Europe
  - 12.3.18.1. Overview
  - 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.18.5. Rest of the Europe Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.3.18.6. Rest of the Europe Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. GMP Biologics Key Manufacturers in Asia Pacific
- 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.6. APAC Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
- 12.4.7. APAC Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
- 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.9. China
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.9.5. China Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.4.9.6. China Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.10. India
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.10.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.10.5. India Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.4.10.6. India Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.14. Indonesia
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.14.5. Indonesia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.4.14.6. Indonesia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.15. Thailand
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.15.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.15.5. Thailand Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.4.15.6. Thailand Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.17. Rest of APAC
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.17.5. Rest of APAC Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.4.17.6. Rest of APAC Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
- 12.5.1. Overview
- 12.5.2. GMP Biologics Key Manufacturers in Latin America
- 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.6. LATAM Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
- 12.5.7. LATAM Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
- 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. GMP Biologics Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.15. Rest of MEA
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.15.5. Rest of MEA Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
  - 12.6.15.6. Rest of MEA Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- GMP Biologics Industry

13.1. Competitive Benchmarking
- 13.1.1. Competitive Dashboard
- 13.1.2. Competitive Positioning
13.2. Company Profiles
- 13.2.1. Samsung Biologics
- 13.2.2. WuXi Biologics
- 13.2.3. Amgen Inc.
- 13.2.4. Pfizer Inc.
- 13.2.5. Roche Holding AG
- 13.2.6. Novartis AG
- 13.2.7. Merck & Co.
- 13.2.8. Bristol Myers Squibb
- 13.2.9. Sanofi
- 13.2.10. Lonza Group
- 13.2.11. Catalent Inc.
- 13.2.12. Thermo Fisher Scientific
- 13.2.13. Cobra Biologics
- 13.2.14. AstraZeneca plc
- 13.2.15. Charles River Laboratories International, Inc.
- 13.2.16. Rentschler Biopharma SE
- 13.2.17. Others

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us